Iain Lingard

This inventor holds 17 USPTO granted patents, primarily in Pharmaceutical Compounds. Top assignees: Boehringer Ingelheim International Gmbh, Centrexion Therapeutics Corporation. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Iain Lingard. Retrieved from https://idiyas.com/inventor/iain-lingard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17

% Patents Active = 100.0

Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 50(Granted Patents)

Company Filing History:

13 out of 1,564

Boehringer Ingelheim International Gmbh

patents

4 out of 36

Centrexion Therapeutics Corporation

patents

Years Active: 2014-2024

Loading Chart...

Areas of Expertise:

Phenyltetrazole Derivatives

Plasma Kallikrein Inhibitors

Somatostatin Receptor Agonists

Morpholine Amides

Heteroarylcarboxamide Derivatives

Bicyclic Ring Systems

Indanyloxyphenyl Compounds

Medicinal Chemistry

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12091399 - Phenyltetrazole derivatives as plasma kallikrein inhibitors (2024-09-17),

2. 10675268 - Somatostatin receptor subtype 4 (SSTR4) agonists (2020-06-09),

3. 10640486 - Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors (2020-05-05),

4. 10577336 - Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists (2020-03-03),

5. 10501440 - Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors (2019-12-10),

6. 10399961 - Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors (2019-09-03),

7. 10183940 - Aryl and heteroaryl-fused tetrahydro-1,4-oxazepine amides as somatostatin receptor subtype 4 (SSTR4) agonists (2019-01-22),

8. 10166214 - Somatostatin receptor subtype 4 (SSTR4) agonists (2019-01-01),

9. 10071974 - Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists (2018-09-11),

10. 9789082 - Somatostatin receptor subtype 4 (SSTR4) agonists (2017-10-17),

11. 9371282 - Somatostatin receptor subtype 4 (SSTR4) agonists (2016-06-21),

12. 9308194 - Indanyloxyphenylcyclopropanecarboxylic acids (2016-04-12),

13. 9012489 - Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament (2015-04-21),

14. 8648118 - Bicyclic ring system substituted amide functionalised phenols as medicaments (2014-02-11),

15. 8648070 - Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments (2014-02-11),

Title: The Innovative Mind of Iain Lingard

Introduction: Iain Lingard, a talented inventor hailing from Monza, Italy, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Iain Lingard has recently been granted patents for his cutting-edge inventions in the areas of artificial intelligence and renewable energy technologies.

Career Highlights: With a career spanning over two decades, Iain Lingard has established himself as a visionary in the world of innovation. His work has revolutionized various industries, from healthcare to sustainable energy solutions.

Collaborations: Throughout his career, Iain Lingard has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life. His collaborative spirit has led to the development of groundbreaking technologies that have had a lasting impact on society.

Conclusion: In conclusion, Iain Lingard's passion for innovation and his relentless pursuit of excellence have solidified his position as a prominent figure in the world of inventors. His contributions continue to inspire future generations of innovators to push the boundaries of what is possible.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]